12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several health care stocks showed significant movement. Cardiff Oncology (CRDF) and Y-mAbs Therapeutics (YMAB) reported Q4 earnings, leading to a 28.6% increase for CRDF and an 8.68% increase for YMAB. Other notable gainers include Kineta (KA), Burning Rock Biotech (BNR), Lucy Scientific Discovery (LSDI), and Xilio Therapeutics (XLO). On the downside, Gritstone Bio (GRTS), Humacyte (HUMA), Cue Health (HLTH), Precision BioSciences (DTIL), Biomerica (BMRA), and Codexis (CDXS) experienced declines, with CDXS also reporting Q4 earnings.
February 29, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Codexis saw an 8.61% decline in stock price following their Q4 earnings report.
The decline in CDXS's stock price is likely due to the market's negative response to their Q4 earnings.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Cardiff Oncology's stock surged 28.6% after reporting Q4 earnings, indicating strong performance.
The significant rise in CRDF's stock price is directly linked to the positive reception of their Q4 earnings report.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Y-mAbs Therapeutics experienced an 8.68% increase in stock price after releasing Q4 earnings.
The increase in YMAB's stock price can be attributed to the market's favorable reaction to their Q4 earnings announcement.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90